Nested Cohort Study to Identify Characteristics That Predict Near-Term Disablement From Lung Cancer Brain Metastases

被引:6
作者
Cheville, Andrea L. [1 ]
Basford, Jeffrey R. [1 ]
Pamey, Ian [2 ]
Yang, Ping [3 ]
Diehn, Felix E. [4 ]
机构
[1] Mayo Clin, Dept Phys Med & Rehabil, Rochester, MN USA
[2] Mayo Clin, Dept Neurosurg, Rochester, MN USA
[3] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA
[4] Mayo Clin, Dept Radiol, Rochester, MN USA
来源
ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION | 2017年 / 98卷 / 02期
基金
美国国家卫生研究院;
关键词
Decision support techniques; Lung neoplasms; Mobility limitation; Neoplasm metastasis; Radiotherapy; Rehabilitation; QUALITY-OF-LIFE; PHYSICAL FUNCTION; RADIOTHERAPY; PERFORMANCE; TRIALS;
D O I
10.1016/j.apmr.2016.08.473
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
Objective: To test whether the presence of patient- and imaging-level characteristics (1) are associated with clinically meaningful changes in mobility among patients with late-stage cancer with metastatic brain involvement, and (2) can predict their risk of near-term functional decline. Design: Prospective nested cohort study. Setting: Quaternary academic medical center. Participants: The study population consisted of a nested cohort of the patients with imaging-confirmed brain metastases (n=66) among a larger cohort of patients with late-stage lung cancer (N=311). Interventions: Not applicable. Main Outcome Measures: Functional evaluations with the Activity Measure for Post-Acute Care Computer Adaptive Test (AM-PAC-CAT) and symptom intensity ratings were collected at monthly intervals for up to 2 years. Results: In exploratory univariate models, whole brain radiation therapy (WBRT) and imaging findings of cerebellar or brainstem involvement were associated with large AM-PAC-CAT score declines reflecting worsening mobility (-4.55, SE 1.12; -2.87, SE, 1.0; and -3.14, SE 1.47, respectively). Also in univariate models, participants with new neurologic signs or symptoms at imaging (-2.48; SE.99), new brain metastases (-2.14, SE.99), or new and expanding metastases (-2.64, SE 1.14) declined significantly. Multivariate exploratory mixed logistic models, including WBRT, cerebellar/brainstem location, presence of new and expanding metastases, and worst pain intensity, had excellent predictive capabilities for AM-PAC-CAT score declines of 7.5 and 10 points (C statistics >= 0.8). Conclusions: Among patients with lung cancer and brain metastases, cerebellar/brainstem location, new and expanding metastases, and treatment with WBRT may predict severe, near-term mobility losses and indicate a need to consider rehabilitation services. (C) 2016 by the AmericanCongress of Rehabilitation Medicine
引用
收藏
页码:303 / 311
页数:9
相关论文
共 24 条
  • [1] Imaging and Clinical Characteristics Predict Near-Term Disablement From Bone Metastases: Implications for Rehabilitation
    Cheville, Andrea L.
    Murthy, Naveen S.
    Basford, Jeffrey R.
    Rose, Peter S.
    Tran, Kenny
    Pittelkow, Thomas P.
    Ringler, Michael. D.
    ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 2016, 97 (01): : 53 - 60
  • [2] Brain metastases as the first symptom of lung cancer: a clinical study from an Asian medical center
    Jin, Jia
    Zhou, Xinli
    Liang, Xiaohua
    Huang, Ruofan
    Chu, Zhaohui
    Jiang, Jingwei
    Zhan, Qiong
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2013, 139 (03) : 403 - 408
  • [3] Irradiation of brain metastases from lung cancer: A retrospective study
    Bergqvist, M
    Brattstrom, D
    Bennmarker, H
    Wagenius, G
    Riska, H
    Brodin, O
    LUNG CANCER, 1998, 20 (01) : 57 - 63
  • [4] Radiotherapy for Brain Metastases from Thyroid Cancer: An Institutional and National Retrospective Cohort Study
    Blomain, Erik
    Berta, Scott
    Hug, Nicholas
    Giao, Duc
    Meola, Antonio
    Binkley, Michael
    Hui, Caressa
    Churilla, Thomas
    Shahsavari, Nastaran
    Desai, Kaniksha
    Chang, Steven
    Soltys, Scott
    Pollom, Erqi
    THYROID, 2022, 32 (07) : 781 - 788
  • [5] Brain metastases as the first symptom of lung cancer: a clinical study from an Asian medical center
    Jia Jin
    Xinli Zhou
    Xiaohua Liang
    Ruofan Huang
    Zhaohui Chu
    Jingwei Jiang
    Qiong Zhan
    Journal of Cancer Research and Clinical Oncology, 2013, 139 : 403 - 408
  • [6] Short-term predictors of stereotactic radiosurgery outcome for untreated single non-small cell lung cancer brain metastases: a restrospective cohort study
    Neto, Eliseu Becco
    Bastos, Dhiego Chaves de Almeida
    Yoshikawa, Marcia Harumy
    Figueiredo, Eberval Gadelha
    de Souza, Francisco de Assis
    Prabhu, Sujit
    NEUROSURGICAL REVIEW, 2024, 47 (01)
  • [7] Risk factors for brain metastases in completely resected small cell lung cancer: a retrospective study to identify patients most likely to benefit from prophylactic cranial irradiation
    Zhu, Hui
    Bi, Yongmin
    Han, Anqin
    Luo, Jingyu
    Li, Minghuan
    Shi, Fang
    Kong, Li
    Yu, Jinming
    RADIATION ONCOLOGY, 2014, 9
  • [8] Osimertinib for EGFR-Mutant Lung Cancer with Brain Metastases: Results from a Single-Center Retrospective Study
    Xie, Lijia
    Nagpal, Seema
    Wakelee, Heather A.
    Li, Gordon
    Soltys, Scott G.
    Neal, Joel W.
    ONCOLOGIST, 2019, 24 (06) : 836 - 843
  • [9] Prognostic factors and long-term survival in surgically treated brain metastases from non-small cell lung cancer
    Enders, Frederik
    Geisenberger, Christoph
    Jungk, Christine
    Bermejo, Justo Lorenzo
    Warta, Rolf
    von Deimling, Andreas
    Herold-Mende, Christel
    Unterberg, Andreas
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2016, 142 : 72 - 80
  • [10] A retrospective study of radiotherapy combined with immunotherapy for patients with baseline brain metastases from non-small cell lung cancer
    Lu, Ruoyu
    Wang, Ziqi
    Tian, Wentao
    Shi, Wen
    Chu, Xianjing
    Zhou, Rongrong
    SCIENTIFIC REPORTS, 2025, 15 (01):